DHX9 as a prognostic biomarker and its biological roles in acute myeloid leukemia
Abstract Background Acute myeloid leukemia (AML) is a highly malignant hematopoietic disease, with low remission and high relapse rates, and there is currently no effective treatment except for acute promyelocytic leukemia. DExH-Box Helicase 9, a member of the DExD/H-box family of helicases, is high...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-09-01
|
| Collection: | BMC Cancer |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12885-025-14708-6 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|